AEVI GENOMIC MEDICINE INC's ticker is GNMX and the CUSIP is 00835P105. A total of 29 filers reported holding AEVI GENOMIC MEDICINE INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,329,000 | -2.7% | 36,500 | 0.0% | 1.64% | +6.3% |
| Q3 2019 | $5,475,000 | +54650.0% | 36,500 | -43.3% | 1.54% | +51300.0% |
| Q2 2019 | $10,000 | -100.0% | 64,390 | +105.1% | 0.00% | -100.0% |
| Q4 2018 | $38,610,000 | 0.0% | 31,390 | 0.0% | 12.28% | +4.5% |
| Q3 2018 | $38,610,000 | +91828.6% | 31,390 | 0.0% | 11.75% | +73356.2% |
| Q2 2017 | $42,000 | – | 31,390 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,070,000 | $1,990,000 | 0.99% |
| 22NW, LP | 155,000 | $288,000 | 0.17% |
| SPHERA FUNDS MANAGEMENT LTD. | 405,000 | $753,000 | 0.15% |
| Broadfin Capital, LLC | 500,000 | $930,000 | 0.11% |
| DLD Asset Management, LP | 237,100 | $438,000 | 0.07% |
| Birchview Capital, LP | 68,000 | $126,000 | 0.07% |
| CARL DOMINO INC | 33,273 | $62,000 | 0.07% |
| R&F Capital Advisors LP | 84,268 | $157,000 | 0.04% |
| TFS CAPITAL LLC | 49,461 | $92,000 | 0.03% |
| SIMON QUICK ADVISORS, LLC | 24,390 | $45,000 | 0.03% |